Page last updated: 2024-08-23

amdinocillin and tobramycin

amdinocillin has been researched along with tobramycin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N	1
Lombardo, F; Obach, RS; Waters, NJ	1
Cars, O; Löwdin, E; Melhus, A; Tängdén, T	1
Bekbergenov, BM; Moroz, AF; Rudzit, EA; Stepanets, TH	1
Green, EA; Hall, S; Hanna, CE; Sattler, FR	1
Pickering, LK; Rutherford, I	1

Trials

1 trial(s) available for amdinocillin and tobramycin

Article	Year
Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infections. The American journal of medicine, 1983, Aug-29, Volume: 75, Issue:2A Topics: Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Penicillanic Acid; Random Allocation; Tobramycin	1983

Article

Year

Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infections.

The American journal of medicine, 1983, Aug-29, Volume: 75, Issue:2A

Topics: Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Penicillanic Acid; Random Allocation; Tobramycin

1983

Other Studies

5 other study(ies) available for amdinocillin and tobramycin

Article	Year
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sweden; Travel; White People; Young Adult	2010
[Comparative study of the antibacterial activity of a number of new antibiotics and their combinations in relation to Pseudomonas aeruginosa]. Antibiotiki, 1979, Volume: 24, Issue:5 Topics: Amdinocillin; Aminoglycosides; Anti-Bacterial Agents; Drug Antagonism; Drug Combinations; Drug Synergism; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin	1979
Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin. The Journal of pharmacology and experimental therapeutics, 1981, Volume: 217, Issue:2 Topics: Amdinocillin; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Gentamicins; Mezlocillin; Netilmicin; Penicillins; Piperacillin; Time Factors; Tobramycin	1981